Thomas Richard Kassberg, CBO & Senior Vice President at Ultragenyx Pharmaceutical Inc. (RARE), sold 3,334 shares at $88.19 ($294K) on 2015-06-10, disclosed to the SEC on 2015-06-12.
Scheduled sale ($294k) by CBO & Senior Vice President under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| Filing → |
| RARE | SELL | 2024-03-05 | $109K | — | Filing → |
| RARE | SELL | 2023-10-24 | $2.6M | — | Filing → |
| RARE | SELL | 2023-03-03 | $178K | — | Filing → |